0B68 Alpdogan, Seyfettin Onder - Thomas Jefferson University - Thomas Jefferson University
Dr. Alpdogan

Seyfettin O. Alpdogan, MD

Contact Dr. Alpdogan

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. A Two-Step Approach to Myeloablative Haploidentical Transplantation: Low Nonrelapse Mortality and High Survival Confirmed in Patients with Earlier Stage Disease
  2. Advances in immune regulation in transplantation
  3. Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT
  4. Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinoma
  5. Recent advances in haploidentical stem cell transplantation
  6. Double Haploidentical Hematopoietic Stem Cell Transplantation Results in Successful Engraftment of Bone Marrow from Both Donors without Graft-versus-Host or Graft-versus-Graft Effects
  7. Immune tolerance and transplantation
  8. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation
  9. Absence of P-sel 12F5 ectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease
  10. Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
  11. STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
  12. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation
  13. Organ-derived dendritic cells have differential effects on alloreactive T cells
  14. IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
  15. Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity
  16. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stein cell transplantation
  17. Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation
  18. DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation
  19. Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cells
  20. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration
0